Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avenir Wellness Solutions Inc AVRW

Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production and sale of the Company’s wellness and beauty products. Sera Labs creates products that use science-backed, proprietary oral and topical formulations. The Company sells over 25 products under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Stri. Sera Labs products are sold direct-to-consumer via online Website orders, including opt-in subscribe and save option, and also online and in-store at national drug, mass retailers, grocery chains and convenience stores and on Amazon.com.


OTCQB:AVRW - Post by User

Post by adamchesson Sep 12, 2018 12:11pm
251 Views
Post# 28605446

CURE partnership with Canopy Growth

CURE partnership with Canopy Growthhttps://ca.proactiveinvestors.com/companies/stocktube/10439/cure-pharmaceutical-joins-forces-with-canopy-growth-in-exclusive-partnership-10439.html

CURE Pharmaceutical joins forces with Canopy Growth in exclusive partnership 

CURE Pharmaceutical Holding Corp (OTCMKTS:CURR) COO Jessica Rousset tells Proactive Investors the drug manufacturing company has signed a deal with Canopy Growth Corp (TSX:WEED, NYSE:CGC), where Canopy will have an exclusive license to CURE's patented, multi-layer oral thin film technology for use with cannabis extracts and biosynthetic cannabinoids.

Rousset says the licence agreement allows CURE to accelerate and expand the impact of its technology by joining forces with Canopy, which has broad market access and resources to bring a product to market.


Bullboard Posts
Next >>